Agency Forms Undergoing Paperwork Reduction Act Review, 40065-40067 [2015-17011]

Download as PDF Federal Register / Vol. 80, No. 133 / Monday, July 13, 2015 / Notices withdrawal requests postmarked no later than January 6, 2016. Comments SUMMARY: EPA issued a notice in the must be received on or before January 6, Federal Register of June 10, 2015, 2016, for those clothianidin registrations concerning amendments to terminate where the 180–day comment period has uses in certain pesticide registrations. not been waived.’’ This document corrects errors in the 3. On page 32948, first column, sections titled ‘‘DATES’’ and ‘‘What paragraph two of Unit II is corrected to action is the agency taking?’’. read as follows: FOR FURTHER INFORMATION CONTACT: ‘‘Unless a request is withdrawn by the Ricardo Jones, Pesticide Re-evaluation chloroxylenol registrant by July 10, Division (7508P), Office of Pesticide 2015, EPA expects to issue orders Programs, Environmental Protection terminating the uses described in Table Agency, 1200 Pennsylvania Ave. NW., 1 of the June 10, 2015, document for the Washington, DC 20460–0001; telephone active ingredient chloroxylenol. Users of number: (703) 347–0493; email address: these pesticides or anyone else desiring jones.ricardo@epa.gov. the retention of a use should contact the applicable registrant directly during this SUPPLEMENTARY INFORMATION: 30–day period. Unless a request is I. General Information withdrawn by the clothianidin registrant by January 6, 2016, EPA A. Does this action apply to me? expects to issue orders terminating the The Agency included in the June 10, uses described in Table 1 of the June 10, 2015, notice a list of those who may be 2015, document for the active ingredient potentially affected by this action. clothianidin. Users of these pesticides B. How can I get copies of this document or anyone else desiring the retention of and other related information? a use should contact the applicable registrant directly during this 180–day The docket for this action, identified period.’’ by docket identification (ID) number Authority: 7 U.S.C. 136 et seq. EPA–HQ–OPP–2015–0317, is available at https://www.regulations.gov or at the Dated: July 6, 2015. Office of Pesticide Programs Regulatory Michael Goodis, Public Docket (OPP Docket) in the Acting Director, Pesticide Re-Evaluation Environmental Protection Agency Division, Office of Pesticide Programs. Docket Center (EPA/DC), West William [FR Doc. 2015–17042 Filed 7–10–15; 8:45 am] Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW., Washington, DC BILLING CODE 6560–50–P 20460–0001. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal FEDERAL ELECTION COMMISSION holidays. The telephone number for the Sunshine Act Meetings Public Reading Room is (202) 566–1744, and the telephone number for the OPP AGENCY: Federal Election Commission. Docket is (703) 305–5805. Please review DATE & TIME: Thursday, July 16, 2015 at the visitor instructions and additional 10:00 a.m. information about the docket available PLACE: 999 E Street NW., Washington, at https://www.epa.gov/dockets. DC (Ninth Floor). II. What does this correction do? STATUS: This meeting will be open to the public. The notice (FR Doc. 2015–14092) ITEMS TO BE DISCUSSED: published in the Federal Register of Correction and Approval of Minutes for June 10, 2015 (80 FR 32947) (FRL– June 18, 2015 9928–01) is corrected as follows: Draft Advisory Opinion 2015–02: Grand 1. On page 32947, second column, Trunk Western Railroad Company— under the heading ‘‘Dates’’, correct Illinois Central Railroad Company paragraph one to add: ‘‘chloroxylenol’’ PAC before the word ‘‘registrations’’ Draft Advisory Opinion 2015–03: wherever it appears. 2. On page 32947, second column, Democracy Rules, Inc. under the heading ‘‘Dates’’, after Draft Advisory Opinion 2015–04: paragraph one, correct to add a new Collective Actions PAC paragraph that reads as follows: ‘‘Unless Proposed Directive 74 on the Timely a request is withdrawn by January 6, Resolution of Enforcement Matters 2016, for clothianidin registrations for Notice to Respondents of Information which the registrant has not requested a Sharing by the Commission waiver of the 180–day comment period, Proposed Statement of Policy Regarding EPA expects to issue orders terminating the Public Disclosure of Closed these uses. The Agency will consider Enforcement Files asabaliauskas on DSK5VPTVN1PROD with NOTICES ACTION: Notice; correction. VerDate Sep<11>2014 19:27 Jul 10, 2015 Jkt 235001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 40065 Policy on Third-Party Appearances Before the Commission to Discuss Advisory Opinions Draft Notice of Disposition on REG 2014–06: Candidate Debates Draft Notice of Availability on REG 2015–03: Contributions from Corporations and Other Organizations to Political Committees Draft Notice of Availability on REG 2015–04: Independent Spending by Corporations, Labor Organizations, Foreign Nationals, and Certain Political Committees Revised Meeting Dates for September— December 2015 Management and Administrative Matters Individuals who plan to attend and require special assistance, such as sign language interpretation or other reasonable accommodations, should contact Shawn Woodhead Werth, Secretary and Clerk, at (202) 694–1040, at least 72 hours prior to the meeting date. PERSON TO CONTACT FOR INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. Shawn Woodhead Werth, Secretary and Clerk of the Commission. [FR Doc. 2015–17275 Filed 7–9–15; 4:15 pm] BILLING CODE 6715–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease Registry [30Day–15–15TG] Agency Forms Undergoing Paperwork Reduction Act Review The Agency for Toxic Substances and Disease Registry (ATSDR) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the E:\FR\FM\13JYN1.SGM 13JYN1 40066 Federal Register / Vol. 80, No. 133 / Monday, July 13, 2015 / Notices burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Promotion of the National ALS Registry to Non-referral Centers—New— Agency for Toxic Substances and Disease Registry (ATSDR). Background and Brief Description ATSDR is requesting a two-year OMB approval for the information collection project entitled ‘‘Promotion of the National ALS Registry to Non-referral Centers’’. ATSDR is authorized by the Public Health Law No: 110–373, ALS Registry Act to (1) develop a system to collect data on amyotrophic lateral sclerosis (ALS) and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, or progress to ALS; and (2) establish a national registry for the collection and storage of such data to develop a population-based registry of cases. ATSDR implemented the National ALS Registry (Registry) in 2009 using an neurologists who do not work at major ALS referral centers. The following objectives are set for this project: (1) To implement a pilot project to conduct educational and promotional outreach activities at non-referral center neurology practices in the U.S., to inform neurologists and their staff about the Registry; (2) To encourage neurologists to inform their patients about the Registry, and to increase persons with ALS selfenrollment in the Registry through the web portal via the use of existing Registry brochures, pamphlets, and factsheets; and (3) To examine the effectiveness of educational and promotional outreach activities by reviewing persons with ALS self-enrollment rates before, during, and after the project period. By increasing self-enrollment rates, ATSDR will be able to produce more accurate estimates of prevalence of ALS, and collect risk-factor survey data from a more representative sample of persons with ALS nationwide which will allow ATSDR to fulfill its congressional mandate under the ALS Registry Act. To achieve these objectives, a four group educational and promotional outreach project respondents has been designed. Data for the study will be gathered by means of initial eligibility phone calls and follow-up phone calls and mailings, for neurologists who do or would diagnose/care for patients with ALS. Train-the trainer sessions will be conducted to educate neurologists about the Registry and key informant interviews with neurologists will be done to better understand their knowledge, attitudes, and beliefs about the Registry, and to gather additional information about the currently deployed Registry materials. Participation is voluntary. The total annual burden hours for the proposed project is 344. There is no cost to the respondents other than their time. algorithm applied to national administrative databases. A selfregistration component was launched in October 2010. The primary goal of the Registry is to obtain more complete information on the likely prevalence of ALS and to better describe the demographic characteristics (age, race, sex, and geographic location) of those with ALS. The secondary goal of the registry is to collect additional information on potential risk factors for ALS including, but not limited to, family history of ALS, smoking history, and military service. The Registry’s case ascertainment methodology required validation; therefore, ATSDR established State and Metropolitan ALS Surveillance Projects (Surveillance Projects). In order to avoid biasing results from the Surveillance Projects’ evaluation of the Registry’s completeness, staff were instructed to not promote the Registry during the surveillance period. The proposed project is a new component to be added to the existing Registry and ALS Surveillance Projects to increase self-enrollment rates of those with ALS. According to the Morbidity and Mortality Weekly Report (MMWR) published in 2014, the proportion of cases identified via self-registration was lower than those identified in the administrative data for the period October 2010–December 2011. On-going self-registration is critical because not all persons with ALS can be identified through the algorithm, and only selfregistering persons with ALS can complete the risk-factor surveys. Therefore, efforts to increase Registry awareness among non-referral center neurology practices/neurologists is needed to increase self-enrollment of persons with ALS. This new information collection aims to evaluate educational and promotional outreach activities among select nonreferral/non-specialty center neurology practices and is a result of the need to promote the Registry among ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents asabaliauskas on DSK5VPTVN1PROD with NOTICES Type of respondents Form name Neurologist Support Staff ............................... Neurologist Support Staff ............................... Neurologist Support Staff ............................... Number of responses per respondent 1,900 380 950 1 1 1 6/60 1/60 3/60 950 1 3/60 190 60 64 21 1 1 1 1 1/60 6/60 6/60 1 Initial Phone Call ............................................ Fax to Determine Provider Status .................. Follow-up Phone Call 1 (One-Week Post Mailing). Follow-up Phone Call 2 (Three Months Post Mailing). Fax to Determine if Mailing was Received .... Train-the-trainer Invitation Phone Call ........... Key Informant Interview Invitation Phone Call Train-the-trainer .............................................. Neurologist Support Staff ............................... Neurologist Support Staff ............................... Neurologist/Neurologist Support Staff ............ Neurologist/Neurologist Support Staff ............ Neurologist/Neurologist Support Staff ............ VerDate Sep<11>2014 19:27 Jul 10, 2015 Jkt 235001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\13JYN1.SGM 13JYN1 Avg. burden per response (in hrs.) 40067 Federal Register / Vol. 80, No. 133 / Monday, July 13, 2015 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondents Form name Neurologist ...................................................... 16 1 Key Informant Interview ................................. Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–17011 Filed 7–10–15; 8:45 am] BILLING CODE 4163–18–P [60Day–15–0920–0573; Docket No. CDC– 2015–0054] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed revisions of the National HIV Surveillance System (NHSS) information collection. This data collection provides the primary population-based data used to describe the epidemiology of HIV in the United States. DATES: Written comments must be received on or before September 11, 2015. ADDRESSES: You may submit comments, identified by Docket No. CDC–2015– 0054 by any of the following methods: • Federal eRulemaking Portal: Regulation.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and VerDate Sep<11>2014 19:27 Jul 10, 2015 Jkt 235001 To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services FOR FURTHER INFORMATION CONTACT: Centers for Disease Control and Prevention SUMMARY: Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. DEPARTMENT OF HEALTH AND HUMAN SERVICES asabaliauskas on DSK5VPTVN1PROD with NOTICES Number of responses per respondent PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 Avg. burden per response (in hrs.) 1 to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project National HIV Surveillance System (NHSS) (OMB Control No. 0920–0573, Expiration 02/29/2016)—Revision— National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC is authorized under Sections 304 and 306 of the Public Health Service Act (42 U.S.C. 242b and 242k) to collect information on cases of human immunodeficiency virus (HIV) and indicators of HIV disease and HIV disease progression including AIDS. Data collected as part of the National HIV Surveillance System (NHSS) are the primary data used to monitor the extent and characteristics of the HIV burden in the United States. HIV surveillance data are used to describe trends in HIV incidence and prevalence and characteristics of infected persons. HIV surveillance data are used widely at the federal, state, and local levels for planning and evaluating prevention programs and health-care services, and allocate funding for prevention and care. As science, technology, and our understanding of HIV have evolved, the NHSS has been updated periodically. CDC, in collaboration with health departments in the 50 states, the District of Columbia, and U.S. dependent areas, conducts national surveillance for cases of HIV infection that includes critical data across the spectrum of HIV disease E:\FR\FM\13JYN1.SGM 13JYN1

Agencies

[Federal Register Volume 80, Number 133 (Monday, July 13, 2015)]
[Notices]
[Pages 40065-40067]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-17011]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Toxic Substances and Disease Registry

[30Day-15-15TG]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Agency for Toxic Substances and Disease Registry (ATSDR) has 
submitted the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the

[[Page 40066]]

burden of the proposed collection of information, including the 
validity of the methodology and assumptions used; (c) Enhance the 
quality, utility, and clarity of the information to be collected; (d) 
Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses; and (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Promotion of the National ALS Registry to Non-referral Centers--
New--Agency for Toxic Substances and Disease Registry (ATSDR).

Background and Brief Description

    ATSDR is requesting a two-year OMB approval for the information 
collection project entitled ``Promotion of the National ALS Registry to 
Non-referral Centers''. ATSDR is authorized by the Public Health Law 
No: 110-373, ALS Registry Act to (1) develop a system to collect data 
on amyotrophic lateral sclerosis (ALS) and other motor neuron disorders 
that can be confused with ALS, misdiagnosed as ALS, or progress to ALS; 
and (2) establish a national registry for the collection and storage of 
such data to develop a population-based registry of cases.
    ATSDR implemented the National ALS Registry (Registry) in 2009 
using an algorithm applied to national administrative databases. A 
self-registration component was launched in October 2010.
    The primary goal of the Registry is to obtain more complete 
information on the likely prevalence of ALS and to better describe the 
demographic characteristics (age, race, sex, and geographic location) 
of those with ALS. The secondary goal of the registry is to collect 
additional information on potential risk factors for ALS including, but 
not limited to, family history of ALS, smoking history, and military 
service.
    The Registry's case ascertainment methodology required validation; 
therefore, ATSDR established State and Metropolitan ALS Surveillance 
Projects (Surveillance Projects). In order to avoid biasing results 
from the Surveillance Projects' evaluation of the Registry's 
completeness, staff were instructed to not promote the Registry during 
the surveillance period.
    The proposed project is a new component to be added to the existing 
Registry and ALS Surveillance Projects to increase self-enrollment 
rates of those with ALS. According to the Morbidity and Mortality 
Weekly Report (MMWR) published in 2014, the proportion of cases 
identified via self-registration was lower than those identified in the 
administrative data for the period October 2010-December 2011. On-going 
self-registration is critical because not all persons with ALS can be 
identified through the algorithm, and only self-registering persons 
with ALS can complete the risk-factor surveys. Therefore, efforts to 
increase Registry awareness among non-referral center neurology 
practices/neurologists is needed to increase self-enrollment of persons 
with ALS.
    This new information collection aims to evaluate educational and 
promotional outreach activities among select non-referral/non-specialty 
center neurology practices and is a result of the need to promote the 
Registry among neurologists who do not work at major ALS referral 
centers. The following objectives are set for this project:
    (1) To implement a pilot project to conduct educational and 
promotional outreach activities at non-referral center neurology 
practices in the U.S., to inform neurologists and their staff about the 
Registry;
    (2) To encourage neurologists to inform their patients about the 
Registry, and to increase persons with ALS self-enrollment in the 
Registry through the web portal via the use of existing Registry 
brochures, pamphlets, and factsheets; and
    (3) To examine the effectiveness of educational and promotional 
outreach activities by reviewing persons with ALS self-enrollment rates 
before, during, and after the project period.
    By increasing self-enrollment rates, ATSDR will be able to produce 
more accurate estimates of prevalence of ALS, and collect risk-factor 
survey data from a more representative sample of persons with ALS 
nationwide which will allow ATSDR to fulfill its congressional mandate 
under the ALS Registry Act.
    To achieve these objectives, a four group educational and 
promotional outreach project respondents has been designed.
    Data for the study will be gathered by means of initial eligibility 
phone calls and follow-up phone calls and mailings, for neurologists 
who do or would diagnose/care for patients with ALS. Train-the trainer 
sessions will be conducted to educate neurologists about the Registry 
and key informant interviews with neurologists will be done to better 
understand their knowledge, attitudes, and beliefs about the Registry, 
and to gather additional information about the currently deployed 
Registry materials.
    Participation is voluntary. The total annual burden hours for the 
proposed project is 344. There is no cost to the respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of      Avg. burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Neurologist Support Staff.............  Initial Phone Call......           1,900               1            6/60
Neurologist Support Staff.............  Fax to Determine                     380               1            1/60
                                         Provider Status.
Neurologist Support Staff.............  Follow-up Phone Call 1               950               1            3/60
                                         (One-Week Post Mailing).
Neurologist Support Staff.............  Follow-up Phone Call 2               950               1            3/60
                                         (Three Months Post
                                         Mailing).
Neurologist Support Staff.............  Fax to Determine if                  190               1            1/60
                                         Mailing was Received.
Neurologist/Neurologist Support Staff.  Train-the-trainer                     60               1            6/60
                                         Invitation Phone Call.
Neurologist/Neurologist Support Staff.  Key Informant Interview               64               1            6/60
                                         Invitation Phone Call.
Neurologist/Neurologist Support Staff.  Train-the-trainer.......              21               1               1

[[Page 40067]]

 
Neurologist...........................  Key Informant Interview.              16               1               1
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-17011 Filed 7-10-15; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.